BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

Published on December 21, 2024

that it has entered into definitive agreements with certain institutional investors for the issuance and sale of 9,679,158 shares of its